We are live on ! Find out more
KIN

Kindred Biosciences, Inc.
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

Back to rankings

82 hedge funds and large institutions have $117M invested in Kindred Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

47% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 19

6% more funds holding

Funds holding: 77 → 82 (+5)

4% more capital invested

Capital invested by funds: $113M → $117M (+$4.16M)

34% less call options, than puts

Call options by funds: $158K | Put options by funds: $239K

Holders
82
Holders Change
+5
Holders Change %
+6.49%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
28
Reduced
19
Closed
8
Calls
$158K
Puts
$239K
Net Calls
-$81K
Net Calls Change
-$406K

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$990K
2
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$880K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$690K
4
BlackRock
BlackRock
New York
+$441K
5
Wells Fargo
Wells Fargo
California
+$320K

Top Sellers

Rank Fund Capital Flow
1
GAI
General American Investors
New York
-$881K
2
GIM
Granahan Investment Management
Massachusetts
-$595K
3
GCP
GSA Capital Partners
United Kingdom
-$186K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$153K
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$153K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$10K +$8.33K +2,048 +776%
Carson Wealth (CWM LLC)
77
Carson Wealth (CWM LLC)
Nebraska
$6K – – –
KCM
78
Kathmere Capital Management
Pennsylvania
$6K – – –
FCMT
79
Founders Capital Management (Texas)
Texas
$6K +$6.1K +1,500 New
Federated Hermes
80
Federated Hermes
Pennsylvania
$1K +$671 +165 New
AIG
81
American International Group
New York
$93 -$2.53K -621 -3%
GCP
82
GSA Capital Partners
United Kingdom
– -$186K -43,260 Closed
Prudential Financial
83
Prudential Financial
New Jersey
– -$124K -28,940 Closed
WG
84
Winton Group
United Kingdom
– -$85K -19,750 Closed
Arrowstreet Capital
85
Arrowstreet Capital
Massachusetts
– -$51K -12,000 Closed
CFO
86
CVA Family Office
Colorado
– -$11K -2,500 Closed
Rockefeller Capital Management
87
Rockefeller Capital Management
New York
– -$4K -1,000 Closed
CSPIA
88
Cary Street Partners Investment Advisory
Virginia
– -$3K -700 Closed
PCM
89
Prelude Capital Management
New York
– -$1K -200 Closed
1 2 3
4

KIN Hedge Fund Activity: Q4 2020 in Review

82 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences, Inc. (KIN) for Q4 2020, worth a combined $117M — up 3.7% from $113M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new KIN positions and 8 closed out — a net gain of 5 holders — while 28 added to existing stakes and 19 trimmed.

The largest buyer was Ariel Investments, adding an estimated $990K. The largest seller was General American Investors, cutting an estimated $881K.

  • 82 institutional investors held Kindred Biosciences, Inc. (KIN) as of Q4 2020, up from 77 in Q3 2020.
  • Funds reported $117M of Kindred Biosciences, Inc. stock for Q4 2020, up 3.7% quarter-over-quarter.
  • 13 funds opened new Kindred Biosciences, Inc. positions in Q4 2020 and 8 closed out, a net change of +5 holders.
  • The largest Kindred Biosciences, Inc. buyer in Q4 2020 was Ariel Investments, an estimated $990K added.
  • The largest Kindred Biosciences, Inc. seller in Q4 2020 was General American Investors, an estimated $881K sold.

Based on aggregated 13F filings for Q4 2020.